Clinical Trial Update: RZ358 Treatment for Congenital Hyperinsulinism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for RZ358 in congenital hyperinsulinism, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• RZ358 (RZ358)

Snippet

Sponsor: Rezolute | Conditions: Congenital Hyperinsulinism | Phase 3 | Status: ACTIVE_NOT_RECRUITING